[Study of non-hypophysiary growth retardation treated with formebolone].
Results of a treatment with a derivative of androstane, named formebolone, are observed in 20 children (12 boys and eight girls), with non-pituitary growth retardation and normal values in hGH stimulation test. Initial heights were, most of them, far below--2 standard deviations and most bone ages showed more than two years retardation in comparison with the chronological ages. Results show a more significant height increase in pubertal cases as well as an acceleration of bone age that does not jeopardize final height.
D000293:Adolescent; D000365:Age Determination by Skeleton; D000734:Androstenediols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy*; D006801:Humans; D008297:Male
D000734:Androstenediols; C002846:formyldienolone
Estudio del retraso de crecimiento no hipofisario tratado con formebolona.